Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Human Cytomegalovirus Envelope Glycoprotein B Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Cytomegalovirus Envelope Glycoprotein B Overall Market Size
2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size: 2021 VS 2028
2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales: 2017-2028
3 Company Landscape
3.1 Top Human Cytomegalovirus Envelope Glycoprotein B Players in Global Market
3.2 Top Global Human Cytomegalovirus Envelope Glycoprotein B Companies Ranked by Revenue
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Companies
3.4 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Companies
3.5 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Cytomegalovirus Envelope Glycoprotein B Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Cytomegalovirus Envelope Glycoprotein B Players in Global Market
3.8.1 List of Global Tier 1 Human Cytomegalovirus Envelope Glycoprotein B Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Cytomegalovirus Envelope Glycoprotein B Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Markets, 2021 & 2028
4.1.2 CSJ-148
4.1.3 CyMVectin
4.1.4 TRL-345
4.1.5 PPCM
4.1.6 Cytomegalovirus Vaccine
4.1.7 Others
4.2 By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue & Forecasts
4.2.1 By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2017-2022
4.2.2 By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2023-2028
4.2.3 By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2017-2028
4.3 By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Sales & Forecasts
4.3.1 By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2017-2022
4.3.2 By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2023-2028
4.3.3 By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2017-2028
4.4 By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2021 & 2028
5.1.2 Infectious Disease
5.1.3 Oncology
5.1.4 Women's Health
5.1.5 Others
5.2 By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue & Forecasts
5.2.1 By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2017-2022
5.2.2 By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2023-2028
5.2.3 By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2017-2028
5.3 By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Sales & Forecasts
5.3.1 By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2017-2022
5.3.2 By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2023-2028
5.3.3 By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2017-2028
5.4 By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2021 & 2028
6.2 By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue & Forecasts
6.2.1 By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2017-2022
6.2.2 By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2023-2028
6.2.3 By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2017-2028
6.3 By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Sales & Forecasts
6.3.1 By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2017-2022
6.3.2 By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2023-2028
6.3.3 By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2017-2028
6.4.2 By Country - North America Human Cytomegalovirus Envelope Glycoprotein B Sales, 2017-2028
6.4.3 US Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.4.4 Canada Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.4.5 Mexico Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2017-2028
6.5.2 By Country - Europe Human Cytomegalovirus Envelope Glycoprotein B Sales, 2017-2028
6.5.3 Germany Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.5.4 France Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.5.5 U.K. Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.5.6 Italy Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.5.7 Russia Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.5.8 Nordic Countries Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.5.9 Benelux Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2017-2028
6.6.2 By Region - Asia Human Cytomegalovirus Envelope Glycoprotein B Sales, 2017-2028
6.6.3 China Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.6.4 Japan Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.6.5 South Korea Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.6.6 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.6.7 India Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2017-2028
6.7.2 By Country - South America Human Cytomegalovirus Envelope Glycoprotein B Sales, 2017-2028
6.7.3 Brazil Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.7.4 Argentina Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales, 2017-2028
6.8.3 Turkey Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.8.4 Israel Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.8.5 Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
6.8.6 UAE Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Astellas Pharma Inc.
7.1.1 Astellas Pharma Inc. Corporate Summary
7.1.2 Astellas Pharma Inc. Business Overview
7.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Major Product Offerings
7.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales and Revenue in Global (2017-2022)
7.1.5 Astellas Pharma Inc. Key News
7.2 Trellis Bioscience, Inc.
7.2.1 Trellis Bioscience, Inc. Corporate Summary
7.2.2 Trellis Bioscience, Inc. Business Overview
7.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Major Product Offerings
7.2.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales and Revenue in Global (2017-2022)
7.2.5 Trellis Bioscience, Inc. Key News
7.3 Vakzine Projekt Management GmbH
7.3.1 Vakzine Projekt Management GmbH Corporate Summary
7.3.2 Vakzine Projekt Management GmbH Business Overview
7.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Major Product Offerings
7.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales and Revenue in Global (2017-2022)
7.3.5 Vakzine Projekt Management GmbH Key News
7.4 VBI Vaccine Inc
7.4.1 VBI Vaccine Inc Corporate Summary
7.4.2 VBI Vaccine Inc Business Overview
7.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Major Product Offerings
7.4.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales and Revenue in Global (2017-2022)
7.4.5 VBI Vaccine Inc Key News
7.5 Vical Incorporated
7.5.1 Vical Incorporated Corporate Summary
7.5.2 Vical Incorporated Business Overview
7.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Major Product Offerings
7.5.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales and Revenue in Global (2017-2022)
7.5.5 Vical Incorporated Key News
8 Global Human Cytomegalovirus Envelope Glycoprotein B Production Capacity, Analysis
8.1 Global Human Cytomegalovirus Envelope Glycoprotein B Production Capacity, 2017-2028
8.2 Human Cytomegalovirus Envelope Glycoprotein B Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Cytomegalovirus Envelope Glycoprotein B Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Cytomegalovirus Envelope Glycoprotein B Supply Chain Analysis
10.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Value Chain
10.2 Human Cytomegalovirus Envelope Glycoprotein B Upstream Market
10.3 Human Cytomegalovirus Envelope Glycoprotein B Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer